Der Charité Campus Benjamin Franklin ist ein Klinikum der Vollversorgung. Seit 1998 gehört es zum Verbund der Charité. Zurück geht das Klinikum auf das 1968 eröffnete Klinikum Steglitz der Freien Universität Berlin. Es liegt im Berliner Ortsteil Lichterfelde des Bezirks Steglitz-Zehlendorf.

During the past decade, Charité-University Medicine Berlin, Campus Benjamin Franklin conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charité-University Medicine Berlin, Campus Benjamin Franklin" #1 sponsor was "Charite University, Berlin, Germany" with 5 trials, followed by "Deutsches Herzzentrum Muenchen" with 1 trials sponsored, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials sponsored, "Impulse Dynamics" with 1 trials sponsored and "Prof. Dr. med. Max. E. Scheulen" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charité-University Medicine Berlin, Campus Benjamin Franklin" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "ClinAssess GmbH" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator, "Einstein center digital future" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Charité-University Medicine Berlin, Campus Benjamin Franklin" are "Coronary Artery Disease" (2 trials), "Accidental Falls" (1 trials), "Advanced Solid Tumors" (1 trials), "Ankylosing Spondylitis" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Charité-University Medicine Berlin, Campus Benjamin Franklin" in a lesser frequency.

Most popular intervention types in "Charité-University Medicine Berlin, Campus Benjamin Franklin" are "Drug" (6 trials), "Other" (3 trials), "Device" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR" (1 trials), "Bendavia (MTP-131)" (1 trials), "Bisoprolol" (1 trials) and "Bleeding assessment tool" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charité-University Medicine Berlin, Campus Benjamin Franklin" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Charité-University Medicine Berlin, Campus Benjamin Franklin". 1 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Charité-University Medicine Berlin, Campus Benjamin Franklin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charité-University Medicine Berlin, Campus Benjamin Franklin, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".